News
Concerns Are Raised By Kidney Research UK Over NICE Process
The National Institute for Health and Care Excellence's (NICE) draught guidance on medicines for COVID-19 patients has received a response from Kidney Research UK.
It comes after the regulatory authority decided to drastically cut the number of therapies offered. The...
News
First Time Getting A Vaccine? 3 Benefits And 3 Risks
Although vaccinations have been around for decades, questions about their safety and effectiveness persist. You, like most people, probably got vaccinated because you believe it to be the safest and most effective way to stay healthy. However, if you're...
News
WHO Report Says That AMR Surveillance Has To Be Strengthened
Common bacterial illnesses are getting more and more resistant to treatments, according to the World Health Organization's (WHO) Global Antimicrobial Resistance and Use Surveillance System (GLASS) report 2022, which includes AMR tendencies for the first time since 2017.
Information from...
Clinical Trials
By 2027, Market For Oligonucleotides Will Be Worth $16.7 Bn
The growth in ongoing clinical trials for oligonucleotide-based therapies in important therapeutic fields like oncology is expected to cause the global oligonucleotide synthesis market to reach $16.7 billion by 2027 during the forecast timeframe, according to a recent market...
News
What Is NMN and Why It’s Becoming More and More Important?
Growing old is inevitable. However, it is possible to reverse the aging process using Nicotinamide Mononucleotide or NMN. Keeping that in mind, I'm going to give you the details of how this molecule works in cells.
What Is NMN?
One of...
News
National Database of Drug Formulations In India A Priority
In an effort to better inform and empower consumers, the Indian government has announced plans to create a comprehensive database on every medicinal composition supplied there.
The Ministry of Health and Family Welfare (MoHFW) of India announced plans to compile...
Drug Research
An Encrypt Medicine Suppresses COVID-19 And Its Variants
Dana-Farber scientists have developed a medication that neutralises SARS-CoV-2, the COVID-19 coronavirus, and every other tested version. The medicine is developed so that natural selection maintains its activity against future viral strains.
The investigational medicine is not an antibody but...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















